Form 10-Q Alexza Pharmaceuticals For: Jun 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Form 10-Q Alexza Pharmaceuticals For: Jun 30

Roth Capital Downgrades Alexza Pharma (ALXA) to Neutral

August 8, 2014 6:44 AM EDT

Roth Capital downgraded Alexza Pharma (NASDAQ: ALXA) from Buy to Neutral with a price target of $5.50 (from $10.00).

For an analyst ratings summary and ratings history on Alexza Pharma click here. For more ratings news on Alexza Pharma click here.

Shares of Alexza Pharma closed at $4.86 yesterday.

... More

Alexza Pharmaceuticals, Inc. (ALXA) Posts Q2 Loss of 34c/Share

August 7, 2014 4:39 PM EDT

Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q2 EPS of ($0.34), $0.33 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $2.24 million.

For earnings history and earnings-related data on Alexza Pharmaceuticals, Inc. (ALXA) click here.

... More